The Eurasian Union (EAEU) is working to implement a submission process that is similar to the eCTD model and also other ICH guidelines. The new regulation affects all marketing authorization holders as well as all new drug applications. Our upcoming webinar is a must-attend for anyone who wants to stay up-to-date and implement the new requirements smoothly.
Understanding the submission requirements in the region
Identifying the technical differences between EAEU and ICH eCTD requirements
Adopting your submission processes to comply with the technical requirements